Brayanna Infinita Laviashna Saputro

Brayanna Infinita Laviashna Saputro

Auto-generated profile, based on publicly available information

Brayanna Infinita Laviashna Saputro

Medical Science Department, Faculty of Medicine, University of Indonesia, Jakarta, 10430, Indonesia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
EWElvan Wiyarta
Elvan Wiyarta
RHRakhmad Hidayat
Rakhmad Hidayat
MKMohammad Kurniawan
Mohammad Kurniawan
BSBryanna Infinita Laviashna Saputro
Bryanna Infinita Laviashna Saputro
IMIndira Laksmi Maharani
Indira Laksmi Maharani
RTRaymond Rubianto Tjandrawinata
Raymond Rubianto Tjandrawinata
Background: Acute ischemic stroke (AIS) requires rapid treatment. Although alteplase is a standard thrombolytic therapy, its limited availability in low-resource settings presents a challenge. Lumbrokinase, a fibrinolytic enzyme isolated from earthworms, has been proposed as an adjunct treatment option. This meta-analysis evaluated efficacy and safety in addition to supportive care. Methods: A systematic review of randomized controlled trials (RCTs) was conducted using multiple databases through July 2024 following PRISMA guidelines. The risk of bias was assessed using RoB 2.0, and evidence quality was graded using GRADE. Publication bias was evaluated using funnel plots. Meta-analyses employed a random-effects model and reported odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals. Primary outcomes included the Barthel Index and NIHSS scores, and secondary outcomes included adverse events and laboratory results. Results: A total of 35 RCTs published between 2010 and 2024 were included. Compared with supportive care alone, lumbrokinase adjunct therapy significantly improved Barthel Index scores (MD = 15.17; 95% CI: 14.60 to 15.74) and reduced NIHSS scores (MD = − 2.01; 95% CI: − 2.06 to − 1.97). Safety analyses revealed no significant increase in adverse events including gastrointestinal discomfort (OR = 1.00; 95% CI: 0.32 to 3.16) and GI bleeding (OR = 1.42; 95% CI: 0.55 to 3.67). Laboratory assessments indicated improvements in aPTT (MD = 1.93; 95% CI: 1.58 to 2.28), platelet aggregation rate (MD = − 205.86; 95% CI, − 206.77 to − 204.96), and D-dimer levels (MD = − 0.04; 95% CI: − 0.05 to − 0.03). Conclusion: Lumbrokinase may safely improve stroke outcomes; however, limited evidence warrants cautious use and further high-quality trials.

31 October 2023 in Journal of Agromedicine and Medical Sciences
Verified
Journal Article
Open access
PDF file
MRMuhammad Ilham Dhiya Rakasiwi
Muhammad Ilham Dhiya Rakasiwi
ASAstrid Mariam Khairani Siregar
Astrid Mariam Khairani Siregar
BSBrayanna Infinita Laviashna Saputro
Brayanna Infinita Laviashna Saputro
FIFathiyah Isbaniah
Fathiyah Isbaniah
LOLily Indriani Octovia
Lily Indriani Octovia
Tuberculosis (TB) and malnutrition are still major public health problems in the world. These two clinical conditions can occur simultaneously and create a vicious cycle that worsens TB infection or nutritional status. This case report aims to examine the relationship between low nutritional status (malnutrition) of patients and death due to pulmonary TB. A 31 year old woman came to the pulmonary clinic of a tertiary hospital in Jakarta for her third month of drug-sensitive anti-TB drug (OAT) treatment control. Three months earlier, the patient underwent a rapid diagnostic test (RDT) to determine OAT resistance. The conclusion of her anthropometric examination was body mass index (BMI) of 15.6 kg/m2. Before being diagnosed with pulmonary TB, she always had difficulty gaining weight. During the course of disease, her weight decreased by 5 kg per month. After undergoing treatment for 6 months, the patient was declared complete after 6 months of therapy, without any improvement in nutritional status. At 1 year follow-up, the patient experienced a relapse of pulmonary TB with a BMI of 13.2 kg/m2. She died 2 months after diagnosis of relapse TB. Improvement in clinical complaints and conversion to bacteriological examination are indications of successful therapy, including improvement in nutritional status. To analyze the relationship between malnutrition and pulmonary TB and death, the authors conducted a comprehensive literature search in the journal databases PubMed, Cochrane, and Scopus, followed by analysis according to the PRISMA 2020 flowchart, for a prognostic cohort study of cases of death in pulmonary TB patients with malnutrition. There is a relationship between BMI and the risk of death in TB patients. Anthropometric measurements, especially BMI, need to be carried out during every physical examination of pulmonary TB cases. Keywords: Body mass index; Malnutrition; Mortality; Tuberculosis